fontex 20 mg
eli lilly norge as - fluoksetinhydroklorid - dispergerbar tablett - 20 mg
lisinopril/hydroklortiazid actavis 20 mg / 12.5 mg
actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 20 mg / 12.5 mg
lisinopril/hydroklortiazid actavis 10 mg / 12.5 mg
actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 10 mg / 12.5 mg
sertraline accord 50 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 50 mg
sertraline accord 100 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 100 mg
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
duloxetine mylan
mylan pharmaceuticals limited - duloksetin - neuralgia; diabetic neuropathies; depressive disorder, major; anxiety disorders - psychoanaleptics, - behandling av store depressiv lidelse, behandling av smerter ved perifer diabetisk nevropati;behandling av generalisert angst lidelse;duloxetine mylan er indisert hos voksne.
carbamazepine essential pharma 125 mg
essential pharma (m) limited - karbamazepin - stikkpille - 125 mg
carbamazepine essential pharma 250 mg
essential pharma (m) limited - karbamazepin - stikkpille - 250 mg
donepezil actavis 10 mg
actavis group ptc ehf - donepezilhydroklorid - tablett, filmdrasjert - 10 mg